Literature DB >> 15703968

Selective dorsal rhizotomy in cerebral palsy to improve functional abilities: evaluation of criteria for selection.

Petra E M van Schie1, R Jeroen Vermeulen, Willem J R van Ouwerkerk, Gert Kwakkel, Jules G Becher.   

Abstract

OBJECTIVES: The aim of this study is to evaluate the effect of selective dorsal rhizotomy (SDR) on functional abilities in a well-defined group of ambulatory children with spastic diplegia.
METHODS: Nine children were selected for SDR (mean age 65 months, range 43-82 months). Gross motor function was measured with the Gross Motor Function Measure (GMFM-88). Self-care was assessed with the Pediatric Evaluation of Disability Inventory (PEDI) and gait pattern was measured with the Edinburgh Visual Gait Score (EGS). There were nine single-case research designs with a 12-month follow-up after surgery.
RESULTS: After 12 months the mean improvement in the total GMFM-88 scores was 8.8%. On an individual level, all patients improved significantly in comparison with baseline. Functional skills and care-giver assistance measured with the PEDI showed significant improvement. Improvement in gait was also found; in particular, better initial contact and heel-lift resulted in an increased EGS.
CONCLUSION: In this well-defined group of ambulatory children SDR had a small but significant positive effect on gross motor function, self-care and gait pattern.

Entities:  

Mesh:

Year:  2005        PMID: 15703968     DOI: 10.1007/s00381-004-1105-1

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  18 in total

1.  Changes in gait at 1 year post-selective dorsal rhizotomy: results of a prospective randomized study.

Authors:  C Graubert; K M Song; J F McLaughlin; K F Bjornson
Journal:  J Pediatr Orthop       Date:  2000 Jul-Aug       Impact factor: 2.324

2.  Selective dorsal rhizotomy: meta-analysis of three randomized controlled trials.

Authors:  John McLaughlin; Kristie Bjornson; Nancy Temkin; Paul Steinbok; Virginia Wright; Ann Reiner; Theodore Roberts; James Drake; Maureen O'Donnell; Peter Rosenbaum; Jason Barber; Anne Ferrel
Journal:  Dev Med Child Neurol       Date:  2002-01       Impact factor: 5.449

3.  Gait changes in children with spastic diplegia after selective dorsal rhizotomy.

Authors:  S S Thomas; M D Aiona; R Pierce; J H Piatt
Journal:  J Pediatr Orthop       Date:  1996 Nov-Dec       Impact factor: 2.324

4.  What does the Ashworth scale really measure and are instrumented measures more valid and precise?

Authors:  Diane L Damiano; Jeffrey M Quinlivan; Bryan F Owen; Patricia Payne; Karen C Nelson; Mark F Abel
Journal:  Dev Med Child Neurol       Date:  2002-02       Impact factor: 5.449

Review 5.  Selective dorsal rhizotomy: efficacy and safety in an investigator-masked randomized clinical trial.

Authors:  J F McLaughlin; K F Bjornson; S J Astley; C Graubert; R M Hays; T S Roberts; R Price; N Temkin
Journal:  Dev Med Child Neurol       Date:  1998-04       Impact factor: 5.449

6.  Foot contact pattern following selective dorsal rhizotomy.

Authors:  J Adams; L D Cahan; J Perry; L M Beeler
Journal:  Pediatr Neurosurg       Date:  1995       Impact factor: 1.162

7.  The SYBAR system: integrated recording and display of video, EMG, and force plate data.

Authors:  J Harlaar; R A Redmeijer; P Tump; R Peters; E Hautus
Journal:  Behav Res Methods Instrum Comput       Date:  2000-02

8.  A randomized clinical trial to compare selective posterior rhizotomy plus physiotherapy with physiotherapy alone in children with spastic diplegic cerebral palsy.

Authors:  P Steinbok; A M Reiner; R Beauchamp; R W Armstrong; D D Cochrane; J Kestle
Journal:  Dev Med Child Neurol       Date:  1997-03       Impact factor: 5.449

9.  The gross motor function measure: a means to evaluate the effects of physical therapy.

Authors:  D J Russell; P L Rosenbaum; D T Cadman; C Gowland; S Hardy; S Jarvis
Journal:  Dev Med Child Neurol       Date:  1989-06       Impact factor: 5.449

10.  Long-term functional outcome after selective posterior rhizotomy.

Authors:  Sandeep Mittal; Jean-Pierre Farmer; Borhan Al-Atassi; Joanne Gibis; Eileen Kennedy; Carlo Galli; Guylaine Courchesnes; Chantal Poulin; Marie-André Cantin; Thierry E Benaroch
Journal:  J Neurosurg       Date:  2002-08       Impact factor: 5.115

View more
  7 in total

Review 1.  Intrathecal baclofen, selective dorsal rhizotomy, and extracorporeal shockwave therapy for the treatment of spasticity in cerebral palsy: a systematic review.

Authors:  Amogh Kudva; Mickey E Abraham; Justin Gold; Neal A Patel; Julian L Gendreau; Yehuda Herschman; Antonios Mammis
Journal:  Neurosurg Rev       Date:  2021-04-19       Impact factor: 3.042

Review 2.  Lumbosacral Dorsal Rhizotomy for Spastic Cerebral Palsy: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2017-07-06

Review 3.  Selective dorsal rhizotomy for spastic cerebral palsy: a review.

Authors:  Paul Steinbok
Journal:  Childs Nerv Syst       Date:  2007-06-06       Impact factor: 1.475

Review 4.  Therapeutic interventions for tone abnormalities in cerebral palsy.

Authors:  Ann H Tilton
Journal:  NeuroRx       Date:  2006-04

Review 5.  SELECTIVE DORSAL RHIZOTOMY IN CEREBRAL PALSY: SELECTION CRITERIA AND POSTOPERATIVE PHYSICAL THERAPY PROTOCOLS.

Authors:  Renata D'Agostini Nicolini-Panisson; Ana Paula Tedesco; Maira Rech Folle; Márcio Vinicius Fagundes Donadio
Journal:  Rev Paul Pediatr       Date:  2018-01-15

6.  Preoperative MRI findings and functional outcome after selective dorsal rhizotomy in children with bilateral spasticity.

Authors:  Sebastian Grunt; Jules G Becher; Petra van Schie; Willem J R van Ouwerkerk; Mazarin Ahmadi; R Jeroen Vermeulen
Journal:  Childs Nerv Syst       Date:  2009-10-13       Impact factor: 1.475

7.  Temporal but not spatial variability during gait is reduced after selective dorsal rhizotomy in children with cerebral palsy.

Authors:  Mustafa Sinan Bakir; Franziska Gruschke; William R Taylor; Ernst Johannes Haberl; Ilya Sharankou; Carsten Perka; Julia F Funk
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.